Based on the latest data from August 2025, CLSK is trading at $9.47, positioning the stock in the undervalued zone below the 8.6x PE multiple boundary of $9.47. The stock is trading right at the threshold between severe undervaluation and the value zone, indicating potential investment opportunity. With PE boundaries ranging from 8.6x ($9.47) to 44.5x ($49.17), the current price suggests the stock is trading at historically attractive valuation levels compared to its earnings capacity. Analyzing the historical trend, CLSK has experienced significant valuation volatility over the past five years. The stock reached extreme overvaluation in early 2021, peaking around $31 in January 2021, well above even the highest PE boundaries at that time. Following this peak, the stock underwent a substantial correction through 2022, falling to severely undervalued levels around $2-3, trading well below all PE multiples. Since late 2022, the stock has shown recovery phases, notably reaching the fair valuation zone (between 15.8x-22.9x PE) during 2024 when prices ranged between $12-19. The recent decline back to the undervalued zone suggests a potential buying opportunity, as the stock has historically demonstrated the ability to move between different PE bands, with the current positioning near the lower PE boundary indicating room for valuation expansion if fundamentals support it.